Literature DB >> 21603991

Effectiveness of postoperative radiotherapy in patients with small oral and oropharyngeal squamous cell carcinoma and concomitant ipsilateral singular cervical lymph node metastasis (pN1) : A meta-analysis.

Maximilian Moergel1, Philipp Meurer, Katharina Ingel, Thomas G Wendt, Bilal Al-Nawas.   

Abstract

BACKGROUND: The positive effect of radiation therapy for patients with advanced oropharyngeal squamous cell carcinoma (OSCC) has been substantially verified. The present work investigated whether a meta-analysis of current data is able to evaluate the effectiveness of postoperative radiotherapy (PORT) in patients with small OSCC (pT1, pT2) and a single ipsilateral lymph node metastasis (pN1).
METHODS: The meta-analysis comprises randomized and non-randomized studies. High-risk tumors were excluded and defined by size ≥ pT3/pT4, lymph node involvement ≥ pN2, or presence of additional histological risk factors, e.g., involved positive resection margins, extra nodal spread of the disease, or lymphangiosis carcinomatosa. The primary outcome analyzed mortality between the different treatment arms.
RESULTS: Only one prospective randomized clinical trial and six retrospective observational studies were adequate for evaluation. Descriptive analysis revealed a marginally higher mortality in the irradiation group (44% vs. 34%). In contrast, a forest plot presentation of two of seven studies with and without events in the control and therapy arms presented an advantage for the irradiation group with the limitation of large heterogeneity and a lack of statistical significance.
CONCLUSION: Present data are poor and exhibit limited internal and external validity; thus, direct comparison was not possible with the eligible studies. Therefore, a meta-analysis of present data may not serve as the basis for a general treatment recommendation but underlines the need of prospective, randomized, controlled clinical trials.

Entities:  

Mesh:

Year:  2011        PMID: 21603991     DOI: 10.1007/s00066-011-2206-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  28 in total

1.  Number and location of radiolabeled, intraoperatively identified sentinel nodes in 48 head and neck cancer patients with clinically staged N0 and N1 neck.

Authors:  J A Werner; A A Dünne; A Ramaswamy; B J Folz; D Brandt; C Külkens; R Moll; B M Lippert
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-02       Impact factor: 2.503

2.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

3.  Value of postoperative radiotherapy in patients with pathologic N1 neck disease.

Authors:  Martin C Jäckel; Petra Ambrosch; Hans Christiansen; Alexios Martin; Wolfgang Steiner
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

4.  Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab.

Authors:  Edwin Bölke; Peter Arne Gerber; Guido Lammering; Matthias Peiper; Anja Müller-Homey; Hildegard Pape; Christian Giro; Christiane Matuschek; Daniela Bruch-Gerharz; Thomas K Hoffmann; Stephan Gripp; Bernhard Homey; Wilfried Budach
Journal:  Strahlenther Onkol       Date:  2008-02       Impact factor: 3.621

5.  Intra-arterial preoperative cytostatic treatment versus preoperative irradiation: A prospective, randomized study of lingual and sublingual carcinomas.

Authors:  G Szabó; J Kreidler; K Hollmann; A Kovács; G Németh; Z Németh; Z Tóth-Bagi; J Barabás
Journal:  Cancer       Date:  1999-10-15       Impact factor: 6.860

6.  Analysis of treatment results for floor-of-mouth cancer.

Authors:  D G Sessions; G J Spector; J Lenox; S Parriott; B Haughey; C Chao; J Marks; C Perez
Journal:  Laryngoscope       Date:  2000-10       Impact factor: 3.325

7.  Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck.

Authors:  Panagiotis Balermpas; Markus Hambek; Oliver Seitz; Claus Rödel; Christian Weiss
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

8.  Effectiveness of adjuvant radiotherapy in patients with oropharyngeal and floor of mouth squamous cell carcinoma and concomitant histological verification of singular ipsilateral cervical lymph node metastasis (pN1-state)--a prospective multicenter randomized controlled clinical trial using a comprehensive cohort design.

Authors:  Maximilian Moergel; Antje Jahn-Eimermacher; Frank Krummenauer; Torsten E Reichert; Wilfried Wagner; Thomas G Wendt; Jochen A Werner; Bilal Al-Nawas
Journal:  Trials       Date:  2009-12-23       Impact factor: 2.279

9.  Carcinoma of the soft palate and the posterior oropharyngeal wall.

Authors:  S Mak-Kregar; R B Keus; A J Balm; F J Hilgers
Journal:  Clin Otolaryngol Allied Sci       Date:  1994-02

10.  Failure in the neck following multimodality treatment for advanced head and neck cancer.

Authors:  B Vikram; E W Strong; J P Shah; R Spiro
Journal:  Head Neck Surg       Date:  1984 Jan-Feb
View more
  6 in total

Review 1.  The evolving role of selective neck dissection for head and neck squamous cell carcinoma.

Authors:  K Thomas Robbins; Alfio Ferlito; Jatin P Shah; Marc Hamoir; Robert P Takes; Primož Strojan; Avi Khafif; Carl E Silver; Alessandra Rinaldo; Jesus E Medina
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-19       Impact factor: 2.503

Review 2.  An individual patient data meta-analysis on characteristics, treatments and outcomes of the glioblastoma/gliosarcoma patients with central nervous system metastases reported in literature until 2013.

Authors:  Sophie Pietschmann; André O von Bueren; Guido Henke; Michael Josef Kerber; Rolf-Dieter Kortmann; Klaus Müller
Journal:  J Neurooncol       Date:  2014-08-27       Impact factor: 4.130

3.  MicroRNA-17-5p post-transcriptionally regulates p21 expression in irradiated betel quid chewing-related oral squamous cell carcinoma cells.

Authors:  S-Y Wu; K-C Lin; J-F Chiou; S-C Jeng; W-H Cheng; C-I Chang; W-C Lin; L-L Wu; H-L Lee; R-J Chen
Journal:  Strahlenther Onkol       Date:  2013-06-20       Impact factor: 3.621

4.  Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developments.

Authors:  Christoph Evers; Christian Ostheimer; Frank Sieker; Dirk Vordermark; Daniel Medenwald
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

5.  MicroRNA-17-5p regulated apoptosis-related protein expression and radiosensitivity in oral squamous cell carcinoma caused by betel nut chewing.

Authors:  Szu-Yuan Wu; Alexander T H Wu; Shing-Hwa Liu
Journal:  Oncotarget       Date:  2016-08-09

6.  Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria.

Authors:  Danielle N Margalit; Assuntina G Sacco; Jay S Cooper; John A Ridge; Richard L Bakst; Beth M Beadle; Jonathan J Beitler; Steven S Chang; Allen M Chen; Tom J Galloway; Shlomo A Koyfman; Carol Mita; Jared R Robbins; C Jillian Tsai; Minh T Truong; Sue S Yom; Farzan Siddiqui
Journal:  Head Neck       Date:  2020-10-23       Impact factor: 3.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.